Chay Ngee Lim

Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies

Christof Kazda, Ying Ding, Ronan P. Kelly et al. · Diabetes Care · 2015 · 215 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Short‐term administration of the glucagon receptor antagonist <scp>LY2409021</scp> lowers blood glucose in healthy people and in those with type 2 diabetes

Raymond P. Kelly, Parag Garhyan, Eyas Raddad et al. · Diabetes Obesity and Metabolism · 2015 · 108 citations

Medicine, Endocrinology, Pharmacology +17

Is high-grade prostatic intraepithelial neoplasia on needle biopsy different in an Asian population: A clinicopathologic study performed in Singapore

Puay Hoon Tan, Hong Wui Tan, Yen Y. Tan et al. · Urology · 2006 · 23 citations

Medicine, Pathology, Urology +17

PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis

Laurence H. Beck, Stephen P. Berasi, J. Brian Copley et al. · Kidney International Reports · 2021 · 18 citations · Full text

Medicine, Nephrology, Renal Pathology +9

Oxygen consumption and resting energy expenditure during phototherapy in full term and preterm newborn infants

Tai Fai Fok, Jun Gu, Chay Ngee Lim et al. · Archives of Disease in Childhood Fetal & Neonatal · 2001 · 12 citations · Full text

Public Health, Child Health, Physiology +11